Viridian Therapeutics, Inc. (VRDN)
22.37
-0.45
(-1.97%)
USD |
NASDAQ |
Oct 23, 16:00
22.36
0.00 (0.00%)
After-Hours: 20:00
Viridian Therapeutics Price to Book Value : 4.491 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.491 |
| October 22, 2026 | 4.581 |
| October 21, 2026 | 4.619 |
| October 20, 2026 | 4.503 |
| October 19, 2026 | 4.176 |
| October 16, 2026 | 3.820 |
| October 15, 2026 | 3.927 |
| October 14, 2026 | 3.690 |
| October 13, 2026 | 3.658 |
| October 12, 2026 | 3.674 |
| October 09, 2026 | 3.746 |
| October 08, 2026 | 3.682 |
| October 07, 2026 | 3.670 |
| October 06, 2026 | 3.658 |
| October 05, 2026 | 3.814 |
| October 02, 2026 | 3.895 |
| October 01, 2026 | 3.812 |
| September 30, 2026 | 4.134 |
| September 29, 2026 | 4.014 |
| September 28, 2026 | 4.129 |
| September 25, 2026 | 4.109 |
| September 24, 2026 | 4.148 |
| September 23, 2026 | 4.302 |
| September 22, 2026 | 4.441 |
| September 21, 2026 | 4.332 |
| Date | Value |
|---|---|
| September 18, 2026 | 4.416 |
| September 17, 2026 | 4.402 |
| September 16, 2026 | 4.505 |
| September 15, 2026 | 4.382 |
| September 14, 2026 | 4.457 |
| September 11, 2026 | 4.264 |
| September 10, 2026 | 4.475 |
| September 09, 2026 | 4.563 |
| September 08, 2026 | 4.651 |
| September 04, 2026 | 4.601 |
| September 03, 2026 | 4.609 |
| September 02, 2026 | 4.573 |
| September 01, 2026 | 4.623 |
| August 31, 2026 | 4.649 |
| August 28, 2026 | 4.633 |
| August 27, 2026 | 4.794 |
| August 26, 2026 | 4.870 |
| August 25, 2026 | 4.854 |
| August 24, 2026 | 4.822 |
| August 21, 2026 | 4.876 |
| August 20, 2026 | 4.918 |
| August 19, 2026 | 4.979 |
| August 18, 2026 | 4.804 |
| August 17, 2026 | 4.635 |
| August 14, 2026 | 4.433 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.556 |
| TG Therapeutics, Inc. | 13.73 |
| Travere Therapeutics, Inc. | 192.33 |
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
Price to Book Value Related Metrics
| PS Ratio | 30.37 |
| Price | 22.37 |
| Earnings Yield | -16.58% |
| Market Cap | 2.533B |